Soleno Therapeutics, Inc.

NasdaqCM SLNO

Soleno Therapeutics, Inc. Share Price on January 14, 2025: USD 42.54

Soleno Therapeutics, Inc. Share Price is USD 42.54 on January 14, 2025, a -5.38% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
  • Soleno Therapeutics, Inc. 52-week high Share Price is USD 59.18 on November 11, 2024, which is 39.12% above the current Share Price.
  • Soleno Therapeutics, Inc. 52-week low Share Price is USD 37.14 on April 12, 2024, which is -12.69% below the current Share Price.
  • Soleno Therapeutics, Inc. average Share Price for the last 52 weeks is USD 47.06.
Key data
Date Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B)
Market news
Loading...
NasdaqCM: SLNO

Soleno Therapeutics, Inc.

CEO Dr. Anish Bhatnagar M.D.
IPO Date Nov. 13, 2014
Location United States
Headquarters 203 Redwood Shores Parkway
Employees 33
Sector Health Care
Industries
Description

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Similar companies

MBRX

Moleculin Biotech, Inc.

USD 1.87

13.33%

BNTC

Benitec Biopharma Inc.

USD 10.38

-0.10%

INZY

Inozyme Pharma, Inc.

USD 1.51

-12.21%

BPTH

Bio-Path Holdings, Inc.

USD 0.84

-10.07%

ANNX

Annexon, Inc.

USD 4.53

-8.30%

ABOS

Acumen Pharmaceuticals, Inc.

USD 1.56

-1.89%

DAWN

Day One Biopharmaceuticals, Inc.

USD 11.16

-3.46%

CAPR

Capricor Therapeutics, Inc.

USD 12.59

-1.02%

PULM

Pulmatrix, Inc.

USD 5.90

-1.50%

ALRN

Aileron Therapeutics, Inc.

USD 2.11

9.33%

StockViz Staff

January 15, 2025

Any question? Send us an email